Actively Recruiting
Study of Quality of Life and Economic Impact in Adults with Primary Sjogren Syndrome With or Without Small Fiber Neuropathy Using Validated Questionnaires
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-02-05
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the impact of small fiber neuropathy SFN on quality of life and economic costs in patients with primary Sjf6gren syndrome, an autoimmune disease mainly affecting women aged 40 to 60. This study aims to confirm the extent of quality of life impairment caused by SFN, analyze clinical or biological factors linked to this impairment, and evaluate the costs related to SFN management compared to conventional therapies. The study includes two groups patients with primary Sjf6gren syndrome who have definite SFN and those without any signs of peripheral neuropathy. Participants will complete validated questionnaires such as SF-36 for quality of life, DN4 for neuropathic pain, EQ5D, ESSPRI, and PROFAD-SSI to assess symptoms and effects. Economic evaluation will consider hospital, drug, and city-care costs over a six-month period. Participants will undergo an inclusion visit during which these questionnaires and data on care resources used over six months will be collected. The primary outcome is the measure of quality of life impairment at three months using the SF-36 scale. Secondary outcomes include various cost assessments and correlations between quality of life and costs. The study is conducted at a single center and aims to provide a comprehensive understanding of SFNs impact on patients with Sjf6gren syndrome.
CONDITIONS
Brief Title
Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
Research Team
D
Damien SÈNE, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here